Alcyone Therapeutics hopes to be a standout star and rising goddess in the central nervous system (CNS) treatment landscape. The Massachusetts biotech unveiled itself Wednesday with $23 million in ...
Expanded collaboration with Nationwide Children's Hospital adds new funding and a third therapeutic candidate (CLN-301) to Alcyone's diversified portfolio of precision CNS therapeutics and delivery ...
Biogen has given Alcyone Therapeutics a starring role in its drug delivery strategy, paying $85 million to buy the biotech and take control of an implant for getting medicines into the spinal canal.
Alcyone’s ThecaFlex DRx™ System is an implantable medical device in development for intrathecal drug delivery CAMBRIDGE, Mass. and LOWELL, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: ...
Biogen and Alcyone Therapeutics (Alcyone) have entered into a collaboration and licensing agreement to develop Alcyone’s ThecaFlex DRx System (ThecaFlex) to improve patient experience and access to ...
LOWELL — Alcyone Lifesciences Inc., a biotech startup that moved its headquarters to the Boott Mill last summer, said it has entered into an “exclusive clinical collaboration” with Houston-based ...
Here's your look at Alcyone: The Last City in this trailer for the upcoming sci-fi interactive novel set at the end of the universe. Centuries from now, in a society left stagnant, you step into the ...
Biogen is set to acquire US-based Alcyone Therapeutics. Biogen has an existing partnership with Alcyone, and both companies are developing a device that has the potential to improve how medications ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback